Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

Biodegradable polymeric nanoparticles have the potential to be safer alternatives to viruses for gene delivery; however, their use has been limited by poor efficacy in vivo. In this work, we synthesize and characterize polymeric gene delivery nanoparticles and evaluate their efficacy for DNA delivery of herpes simplex virus type I thymidine kinase (HSVtk) combined with the prodrug ganciclovir (GCV) in a malignant glioma model. We investigated polymer structure for gene delivery in two rat glioma cell lines, 9L and F98, to discover nanoparticle formulations more effective than the leading commercial reagent Lipofectamine 2000. The lead polymer structure, poly(1,4-butanediol diacrylate-co-4-amino-1-butanol) end-modified with 1-(3-aminopropyl)-4-methylpiperazine, is a poly(β-amino ester) (PBAE) and formed nanoparticles with HSVtk DNA that were 138 ± 4 nm in size and 13 ± 1 mV in zeta potential. These nanoparticles containing HSVtk DNA showed 100% cancer cell killing in vitro in the two glioma cell lines when combined with GCV exposure, while control nanoparticles encoding GFP maintained robust cell viability. For in vivo evaluation, tumor-bearing rats were treated with PBAE/HSVtk infusion via convection-enhanced delivery (CED) in combination with systemic administration of GCV. These treated animals showed a significant benefit in survival (p = 0.0012 vs control). Moreover, following a single CED infusion, labeled PBAE nanoparticles spread completely throughout the tumor. This study highlights a nanomedicine approach that is highly promising for the treatment of malignant glioma.

[1]  Yiyun Huang,et al.  Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma , 2013, Proceedings of the National Academy of Sciences.

[2]  Erik Tryggestad,et al.  Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides , 2010, Nature Medicine.

[3]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma. , 2008, Nanomedicine.

[5]  Susan M. Chang,et al.  Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Neumann,et al.  Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  J. Voges,et al.  Liposome-mediated suicide gene therapy in humans. , 2005, Methods in enzymology.

[8]  S. Yla-Herttuala,et al.  Gene therapy for malignant glioma: current clinical status. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  N. Rainov.  A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. , 2000, Human gene therapy.

[10]  Nupura S. Bhise,et al.  The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures. , 2010, Biomaterials.

[11]  D M Coen,et al.  Experimental therapy of human glioma by means of a genetically engineered virus mutant , 1991, Science.

[12]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[13]  I. Siu,et al.  Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats. , 2011, Neuro-oncology.

[14]  P. Forgez,et al.  Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice , 2014, PloS one.

[15]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Martuza,et al.  Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial , 2000, Gene Therapy.

[17]  G. Dunn,et al.  Emerging Insights into Barriers to Effective Brain Tumor Therapeutics , 2014, Front. Oncol..

[18]  P. Burger,et al.  Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. , 1994, Cancer research.

[19]  H. Brem,et al.  The role of minocycline in the treatment of intracranial 9L glioma. , 1995, Journal of neurosurgery.

[20]  M. Tomicic,et al.  Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation , 2002, Oncogene.

[21]  J. Sunshine,et al.  Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. , 2012, Molecular pharmaceutics.

[22]  Jinyuan Zhou,et al.  Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts , 2008, NMR in biomedicine.

[23]  G. Gallia,et al.  Multiple resections for patients with glioblastoma: prolonging survival. , 2013, Journal of neurosurgery.

[24]  Q. Luo,et al.  Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system. , 2008, Journal of biomedical optics.

[25]  J. Green,et al.  2011 Rita Schaffer Lecture: Nanoparticles for Intracellular Nucleic Acid Delivery , 2012, Annals of Biomedical Engineering.

[26]  L. Rakić,et al.  Characterization of 9L Glioma Model of the Wistar Rat , 2003, Journal of Neuro-Oncology.

[27]  F. Moolten.  Drug sensitivity ("suicide") genes for selective cancer chemotherapy. , 1994, Cancer gene therapy.

[28]  R. Bjerkvig,et al.  Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions , 2000, Cancer Gene Therapy.

[29]  H. Namba,et al.  Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells. , 2011, Cancer genomics & proteomics.

[30]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[31]  R. Weichselbaum,et al.  Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[32]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[33]  Martin G Pomper,et al.  Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s. , 2013, Journal of biomedical materials research. Part A.

[34]  R. Grossman,et al.  Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  L. Mariani,et al.  A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. , 1999, Human gene therapy.

[36]  K. Kataoka,et al.  Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Moolten Fl.  Drug sensitivity ("suicide") genes for selective cancer chemotherapy. , 1994 .

[38]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[39]  J. Engbersen,et al.  Optimization of poly(amido amine)s as vectors for siRNA delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[40]  M. Berger,et al.  Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging , 2004, Cancer Research.

[41]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[42]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[43]  J. DiMaio,et al.  Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. , 1994, Surgery.

[44]  C. Denning,et al.  Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes. , 1997, Human gene therapy.

[45]  Erkki Ruoslahti,et al.  Targeted quantum dot conjugates for siRNA delivery. , 2007, Bioconjugate chemistry.

[46]  H. Wakimoto,et al.  Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy , 2014, Front. Microbiol..

[47]  J. Sunshine,et al.  Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma. , 2011, Biomaterials.

[48]  E. Chiocca,et al.  Strategies in Gene Therapy for Glioblastoma , 2013, Cancers.

[49]  Andrew Burgess,et al.  Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance , 2010, Proceedings of the National Academy of Sciences.

[50]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[51]  S. Freeman,et al.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.

[52]  J. Benoit,et al.  Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. , 2009, Biomaterials.

[53]  V. Tse,et al.  Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ. , 2001, Biochemical and biophysical research communications.

[54]  H. Brem,et al.  Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model , 2010, Neurosurgery.

[55]  R. Tamargo,et al.  Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. , 1993, Cancer research.

[56]  E. A. Chiocca,et al.  Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. , 2000, Journal of neurosurgery.

[57]  H. Okada,et al.  Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells , 2001, Gene Therapy.

[58]  N. Peppas,et al.  Oral delivery of small RNA and DNA. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[59]  S. Ylä-Herttuala,et al.  AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  J. Sunshine,et al.  Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cells. , 2014, Bioconjugate chemistry.

[61]  Y. Won,et al.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[62]  J. Sunshine,et al.  Poly(β-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo , 2012, PloS one.

[63]  L. Yarmus,et al.  Suicide Gene Therapy for Cancer - Current Strategies. , 2013, Journal of genetic syndromes & gene therapy.

[64]  E. Duh,et al.  Gene delivery nanoparticles specific for human microvasculature and macrovasculature. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[65]  L. Mariani,et al.  A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir , 1999 .

[66]  S. Shamim,et al.  Neurosurgery , 1943 .

[67]  A. Olivi,et al.  Local Immunotherapy with Interleukin-2 Delivered from Biodegradable Polymer Microspheres Combined with Interstitial Chemotherapy: A Novel Treatment for Experimental Malignant Glioma , 2003, Neurosurgery.

[68]  N. Nishiyama,et al.  Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. , 2009, Biomacromolecules.

[69]  I. Pollack,et al.  Cytokine gene therapy for malignant glioma , 2004, Expert opinion on biological therapy.

[70]  D. Brat,et al.  Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. , 2000, Journal of neurosurgery.

[71]  Achim Goepferich,et al.  Layer-by-layer assembled gold nanoparticles for siRNA delivery. , 2009, Nano letters.

[72]  Chad A. Mirkin,et al.  Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma , 2013, Science Translational Medicine.

[73]  M. Sanson,et al.  Connexin 43–mediated bystander effect in two rat glioma cell models , 2002, Cancer Gene Therapy.

[74]  Forrest M Kievit,et al.  Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O6-Benzylguanine to Brain Tumors , 2014, ACS nano.

[75]  Alfredo Quiñones-Hinojosa,et al.  Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo , 2014, ACS nano.

[76]  Jordan J. Green,et al.  Bioreducible Cationic Polymer-Based Nanoparticles for Efficient and Environmentally Triggered Cytoplasmic siRNA Delivery to Primary Human Brain Cancer Cells , 2014, ACS nano.

[77]  M. Breunig,et al.  Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Robert Langer,et al.  A Combinatorial Polymer Library Approach Yields Insight into Nonviral Gene Delivery , 2008 .

[79]  Daniel G. Anderson,et al.  Small‐Molecule End‐Groups of Linear Polymer Determine Cell‐type Gene‐Delivery Efficacy , 2009, Advanced materials.

[80]  J. Sunshine,et al.  Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. , 2011, Biomacromolecules.

[81]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[82]  Daniel G. Anderson,et al.  Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity. , 2012, Biomaterials.

[83]  F. Gage,et al.  Thymidine kinase-mediated killing of rat brain tumors. , 1993, Journal of neurosurgery.

[84]  M. Monsigny,et al.  Efficient gene transfer by histidylated polylysine/pDNA complexes. , 1999, Bioconjugate chemistry.

[85]  G. Schackert,et al.  Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. , 2013, Pharmacology & therapeutics.

[86]  H. Yamasaki,et al.  Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. , 2000, Cancer research.

[87]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[88]  D. Shewach,et al.  Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. , 1998, Human gene therapy.

[89]  D. Shewach,et al.  Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells. , 1999, Cancer research.

[90]  S. Tzeng,et al.  Subtle Changes to Polymer Structure and Degradation Mechanism Enable Highly Effective Nanoparticles for siRNA and DNA Delivery to Human Brain Cancer , 2013, Advanced healthcare materials.

[91]  K Wienhard,et al.  Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas , 2001, The Lancet.

[92]  J. Sunshine,et al.  The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. , 2013, Journal of the American Chemical Society.

[93]  Jingxuan Yang,et al.  Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets , 2012, Cancer investigation.